Prostata-MRT

Professor Hamm erklärt DWI-MRT der Prostata

Prostata-Massage, die hilft

Der Radiologe. Das Prostatakarzinom ist in Deutschland die häufigste Krebserkrankung des Mannes, wobei ein deutlicher Unterschied zwischen Inzidenz und Mortalität besteht. Die Detektion des Prostatakarzinoms basiert auf klinischer und laborchemischer Untersuchung Prostata-MRT sowie der transrektalen Ultraschalluntersuchung mit randomisierter Biopsie.

Die multiparametrische MR-Tomographie Prostata-MRT zur Prostata-MRT des Prostatakarzinoms, insbesondere bei negativer Biopsie Prostata-MRT einer erneuten Biopsie Prostata-MRT diagnostische Informationen liefern. Zudem wird Prostata-MRT die MRT-Ultraschall-Fusionsbiopsie in der Diagnostik eingesetzt, wodurch die Detektionsrate Prostata-MRT Prostatakarzinoms deutlich gesteigert werden kann.

Prostate cancer is the Prostata-MRT common form of cancer in Prostata-MRT in Germany; however, there is a distinct difference between incidence and mortality. The detection of prostate cancer is based on clinical and laboratory testing using serum prostate-specific antigen PSA levels and transrectal ultrasound with randomized biopsy.

Multiparametric MR imaging of the prostate can provide valuable diagnostic information for detection of Prostata-MRT cancer, especially after negative results of a biopsy prior to repeat biopsy. In addition the use of MR ultrasound fusion-guided biopsy has gained in diagnostic importance and has increased the prostate cancer detection rate. The prostate imaging reporting and data system PI-RADS classification has standardized the reporting of prostate MRI which has positively influenced the acceptance by urologists.

Skip to main content. Advertisement Hide. Authors Authors and affiliations P. Asbach M. Haas B. Leitthema First Online: 29 Prostata-MRT Klinisches Problem Das Prostatakarzinom ist in Deutschland die häufigste Krebserkrankung des Mannes, wobei ein deutlicher Unterschied zwischen Inzidenz und Mortalität besteht. Prostata-MRT Standardverfahren Die Detektion des Prostatakarzinoms basiert auf klinischer und laborchemischer Untersuchung prostataspezifisches-Antigen[PSA]-Wert sowie der transrektalen Ultraschalluntersuchung mit randomisierter Biopsie.

Diagnostik Die multiparametrische MR-Tomographie kann zur Detektion des Prostatakarzinoms, insbesondere bei negativer Biopsie vor einer erneuten Biopsie wertvolle Prostata-MRT Informationen liefern. Leistungsfähigkeit Prostata-MRT wird zunehmend die MRT-Ultraschall-Fusionsbiopsie in der Prostata-MRT eingesetzt, Prostata-MRT die Detektionsrate des Prostatakarzinoms deutlich gesteigert werden kann. MR imaging of the prostate. Clinical Prostata-MRT Prostate cancer is the most Prostata-MRT form of cancer in men in Germany; however, there is a distinct difference Prostata-MRT incidence and mortality.

Standard treatment The detection of prostate cancer is based on clinical and laboratory testing using serum prostate-specific antigen PSA levels and transrectal ultrasound with randomized biopsy. Diagnostic work-up Multiparametric MR imaging of the prostate can provide Prostata-MRT diagnostic information for detection of prostate cancer, especially after negative results of a biopsy prior to repeat biopsy. Prostata-MRT In addition the use of MR ultrasound fusion-guided biopsy has gained Prostata-MRT diagnostic importance and has increased Prostata-MRT prostate cancer detection rate.

Achievements and practical recommendations The prostate imaging reporting and data system PI-RADS classification has standardized the reporting of prostate MRI which has positively influenced the acceptance by urologists. This is a preview of subscription content, log Prostata-MRT to check access. Einhaltung ethischer Richtlinien Interessenkonflikt P.

Asbach, Prostata-MRT. Haas und B. Hamm geben an, dass kein Interessenkonflikt besteht. Baur AD, Maxeiner A, Franiel T et al Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate.

Zugegriffen: Juli Google Scholar. Franiel T, Hamm B, Hricak H Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer.

Hamoen EH, de Rooij M, Witjes JA Use of the prostate imaging reporting Prostata-MRT data system Prostata-MRT for prostate cancer detection Prostata-MRT multiparametric magnetic resonance imaging: a diagnostic meta-analysis. Medved M, Prostata-MRT S, Yousuf A, Oto A MR imaging of the prostate and adjacent anatomic structures before, during, and after ejaculation: qualitative and quantitative evaluation.

Muller BG, Shih JH, Sankineni S et al Prostate cancer: interobserver agreement and accuracy with the revised prostate imaging reporting and data system at multiparametric MR imaging. Epub ahead Prostata-MRT print. Prostate cancer: diagnosis and treatment. Nowak J, Malzahn U, Baur AD et al The value of ADC, T2 signal intensity, and a combination of both parameters to assess gleason score and primary gleason grades in patients with known prostate Prostata-MRT. Acta Radiol Epub ahead of print.

Pokorny MR, de Rooij M, Duncan E et al Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance MR Prostata-MRT with Prostata-MRT MR-guided biopsy in men without previous prostate biopsies.

Schouten MG, Hoeks CM, Bomers JG et al Location of prostate cancers determined by multiparametric and MRI-guided biopsy in patients with Prostata-MRT prostate-specific antigen level and Prostata-MRT least one negative transrectal ultrasound-guided biopsy. Asbach 1 Email author M.

Haas 1 B. Hamm 1 1. Personalised recommendations. Cite article How to cite? ENW EndNote. Buy options.